The Burrill Report

QB3 Lands More Big Pharma Muscle to Launch Startups

The University of California’s QB3 has been at the forefront of finding innovative ways to work with industry to address the gap in funding translational research and take steps to ensure promising discoveries don’t languish in university labs. A recent series of agreements at QB3 highlight its continued efforts to do just that. We spoke to Doug Crawford, director of industry alliances and associate executive director of QB3, about the institute’s new agreements with Roche and Bayer, the development of additional incubator space to hatch new startups, and why QB3 has succeeded where others have stumbled.

May 31, 2013
http://www.burrillreport.com/article-qb3_lands_more_big_pharma_muscle_to_launch_startups.html